These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.
    Author: Yamada J, Hamuro J, Terai K, Kinoshita S.
    Journal: Transplantation; 2007 Oct 15; 84(7):899-907. PubMed ID: 17984844.
    Abstract:
    BACKGROUND: Corneal allograft rejection is mediated by a Th1-type response. Because major histocompatibility complex (MHC)-compatible allografts are the prerequisite for efficient graft survival by reducing the Th1 response, we explored a new strategy for the acceptance of (MHC+minor H)-disparate allografts. METHODS: N,N'-diacetyl-L-cystine dimethylester (NM2) reduces the intracellular glutathione content (icGSH) in antigen-presenting cells (APCs) and down-regulates Th1 responses. Therefore, we subconjunctivally (scj) injected NM2 into donor- and/or recipient mice on days 1, 4, and 7 before penetrating keratoplasty. C57BL/10, B10.D2, or CBF1 corneal allografts were then placed on neovascularized graft beds of BALB/c mice. Corneal grafting was also performed between CBF1 and B6C3F1 mice. RESULTS: The saline-injected controls rejected all allografts within 3 weeks. Minor H-only-disparate B10.D2 allografts survived indefinitely after the intraperitoneal (ip) (65.0%) and scj (71.4%) injection of NM2 (P<0.0001). MHC+minor H-disparate C57BL/10 allograft survival was prolonged only by scj injection of NM2 (median survival time [MST]=43.6+/-1.5, P<0.001); there was no indefinite allograft survival. Allelic-gene semi-matched CBF1 grafts survived indefinitely after ip (75.0%) or scj (86.6%) delivery of NM2 and 50% of the B6C3F1 grafts survived indefinitely only after scl NM2 injection; no control grafts survived (MST=18.9+/-1.1, P<0.0001). CONCLUSIONS: The local application of NM2 improved the survival of MHC-disparate allografts. Allelic-gene semi-matching, combined with the local induction of APCs with reduced icGSH, resulted in allograft survival comparable to the survival of MHC-matched grafts.
    [Abstract] [Full Text] [Related] [New Search]